Spinocerebellar Ataxia Type 29

Neurology·MeSH: Liver Cirrhosis, Biliary

Prevalence

5.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Spinocerebellar Ataxia Type 29?

There are 1 clinical trial targeting Spinocerebellar Ataxia Type 29 tracked by BioSniper.

What is the prevalence of Spinocerebellar Ataxia Type 29?

The estimated prevalence of Spinocerebellar Ataxia Type 29 is approximately 5.0 per 100,000 population.

Deep-dive into Spinocerebellar Ataxia Type 29

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Spinocerebellar Ataxia Type 29 — Drugs in Development & Clinical Trials | BioSniper